Dusigitumab

Dusigitumab
Monoclonal antibody
Type ?
Source Human
Target ILGF2
Clinical data
ATC code none
Identifiers
CAS Number 1204390-13-5
IUPHAR/BPS 7749
ChemSpider none
Chemical and physical data
Formula C6372H9824N1700O2016S54
Molar mass 151 kg/mol

Dusigitumab is a human monoclonal antibody designed for the treatment of cancer. It binds to IGLF2.[1]

This drug was developed by MedImmune, LLC.

References

  1. Statement On A Nonproprietary Name Adopted By The USAN Council - Dusigitumab, American Medical Association.
This article is issued from Wikipedia - version of the 5/30/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.